# Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)

> **NCT07469293** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Southwest Hospital, China** · enrollment: 488 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **PROCEDURE:** Intra-arterial thrombolysis
- **OTHER:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07469293
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469293, "Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07469293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*